These findings generally correspond to the earlier findings of the authors demonstrating that Se-deficiency in Scly−/− mice resulted in obesity, hyperleptinemia, insulin resistance, and reduced hepatic GPX1 and Selenos levels in parallel with decreased circulating Selenop [236]. Here, SELENOP is linked to obesity disorder.